Literature DB >> 34719502

Improving Detection of Amnestic Mild Cognitive Impairment with Sex-Specific Cognitive Norms.

Erin E Sundermann1, Lisa L Barnes2,3, Mark W Bondi1,4, David A Bennett2,3, David P Salmon5, Pauline M Maki6.   

Abstract

BackgroundDespite a female advantage in verbal memory, normative data for verbal memory tests used to diagnose Alzheimer's disease (AD) dementia and amnestic mild cognitive impairment (aMCI) often are not sex-adjusted.ObjectiveTo determine whether sex-adjusted norms improve aMCI diagnostic accuracy when accuracy was evaluated by progression to AD dementia over time.MethodsNon-sex-specific and sex-specific verbal memory test norms were incorporated into Jak/Bondi aMCI criteria and applied to older (age 65-90) non-demented women (N = 1,036) and men (N = 355) from the Rush Memory and Aging Project. Using sex-specific aMCI diagnosis as the "true" condition versus non-sex-specific aMCI diagnosis as the "predicted" condition, we identified True Positives, False Positives, True Negatives, and False Negatives and compared AD dementia risk over 10 years among groups.ResultsRates of aMCI were higher in men versus women (χ2 = 15.39, p < 0.001) when determined based on typical diagnostic criteria, but this difference reversed when using sex-specific diagnostic criteria (χ2 = 8.38, p = 0.004). We identified 8%of women as False Negatives and 12%of men as False Positives. Risk of incident AD dementia in False Positive men was significantly lower than in True Positive men (HR = 0.26, 95%CI = 0.12-0.58, p = 0.001). Risk of incident AD dementia in False Negative women was substantially higher than in True Negative women (HR = 3.11, 95%CI = 2.09-4.63, p < 0.001).ConclusionResults suggest that previous reports of higher aMCI rates in men versus women may be an artifact of non-sex-adjusted norms/cut-scores. Incorporation of sex-specific norms/cut-scores for verbal memory impairment into aMCI diagnostic criteria may improve diagnostic accuracy and avoid diagnostic errors in approximately 20%.

Entities:  

Keywords:  Amnestic mild cognitive impairment; diagnosis; incident Alzheimer’s disease; sex differences; verbal memory

Mesh:

Year:  2021        PMID: 34719502     DOI: 10.3233/JAD-215260

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  2 in total

1.  Digital biomarkers and sex impacts in Alzheimer's disease management - potential utility for innovative 3P medicine approach.

Authors:  Robbert L Harms; Alberto Ferrari; Irene B Meier; Julie Martinkova; Enrico Santus; Nicola Marino; Davide Cirillo; Simona Mellino; Silvina Catuara Solarz; Ioannis Tarnanas; Cassandra Szoeke; Jakub Hort; Alfonso Valencia; Maria Teresa Ferretti; Azizi Seixas; Antonella Santuccione Chadha
Journal:  EPMA J       Date:  2022-06-06       Impact factor: 8.836

2.  Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective.

Authors:  Michelle M Mielke; Neelum T Aggarwal; Clara Vila-Castelar; Puja Agarwal; Eider M Arenaza-Urquijo; Benjamin Brett; Anna Brugulat-Serrat; Lyndsey E DuBose; Willem S Eikelboom; Jason Flatt; Nancy S Foldi; Sanne Franzen; Paola Gilsanz; Wei Li; Alison J McManus; Debora Melo van Lent; Sadaf Arefi Milani; C Elizabeth Shaaban; Shana D Stites; Erin Sundermann; Vidyani Suryadevara; Jean-Francoise Trani; Arlener D Turner; Jet M J Vonk; Yakeel T Quiroz; Ganesh M Babulal
Journal:  Alzheimers Dement       Date:  2022-04-08       Impact factor: 16.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.